DOUGLAS PAWLING: Open Payments
NPI 1740731421 · WEEKI WACHEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 31 payments from 11 companies in 2025. Trend: 2023 $1,048 · 2024 $992 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $223 |
| Novo Nordisk Inc | 5 | $116 |
| Exact Sciences Corporation | 6 | $103 |
| Amgen Inc. | 2 | $34 |
| Abbott Laboratories | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
Products named: AIRSUPRA, FARXIGA, Cologuard Collection Kit, Ozempic, Wegovy, JARDIANCE, OTEZLA, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
